Dennis Mcloughlin

CIK 1752004 · View on SEC EDGAR ↗

Insider

First SEC filing: Sept. 7, 2018 · Latest: Sept. 7, 2018

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 9 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

9 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
June 7, 2023 PCRX S 1,057 $37.86 $40,018 38,115 Direct -2.70% Disposed -36.4% (price as of 2026-08-20)
June 6, 2023 PCRX S 1,014 $38.99 $39,536 39,172 Direct -2.52% Disposed -38.2% (price as of 2026-08-20)
June 6, 2022 PCRX S 2,140 $61.37 $131,332 31,820 Direct -6.30% Disposed -60.8% (price as of 2026-08-20)
June 4, 2021 PCRX S 1,895 $61.04 $115,671 27,541 Direct -6.44% Disposed -60.5% (price as of 2026-08-20)
June 4, 2020 PCRX S 1,447 $46.33 $67,040 14,898 Direct -8.85% Disposed -48.0% (price as of 2026-08-20)
Dec. 16, 2019 PCRX S 3,671 $45.79 $168,095 16,116 Direct -18.55% Disposed -47.4% (price as of 2026-08-20)
June 4, 2019 PCRX S 1,099 $42.91 $47,158 13,822 Direct -7.37% Disposed -43.9% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
June 8, 2022 PCRX Stock Option (Right to Buy) Common Stock (19,900) $59.39 June 8, 2032 19,900 Acquired
June 9, 2021 PCRX Stock Option (Right to Buy) Common Stock (15,000) $60.96 June 9, 2031 15,000 Acquired
June 9, 2020 PCRX Stock Option (Right to Buy) Common Stock (35,000) $47.65 June 9, 2030 35,000 Acquired
June 5, 2019 PCRX Stock Option (Right to Buy) Common Stock (33,800) $43.54 June 5, 2029 33,800 Acquired
Sept. 5, 2018 PCRX Stock Option (Right to Buy) Common Stock (20,000) $46.55 Aug. 29, 2028 20,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 10 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Sept. 7, 2018 PCRX Common Stock 14,833 Direct
Sept. 7, 2018 PCRX Stock Option (Right to Buy)→ Common Stock (20,000) 20,000 Direct
Sept. 7, 2018 PCRX Stock Option (Right to Buy)→ Common Stock (47,250) 47,250 Direct
Sept. 7, 2018 PCRX Stock Option (Right to Buy)→ Common Stock (6,000) 6,000 Direct
Sept. 7, 2018 PCRX Stock Option (Right to Buy)→ Common Stock (10,000) 10,000 Direct
Sept. 7, 2018 PCRX Stock Option (Right to Buy)→ Common Stock (3,000) 3,000 Direct
Sept. 7, 2018 PCRX Stock Option (Right to Buy)→ Common Stock (6,000) 6,000 Direct
Sept. 7, 2018 PCRX Stock Option (Right to Buy)→ Common Stock (2,400) 2,400 Direct
Sept. 7, 2018 PCRX Stock Option (Right to Buy)→ Common Stock (3,500) 3,500 Direct
Sept. 7, 2018 PCRX Stock Option (Right to Buy)→ Common Stock (10,623) 10,623 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

PCRX

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2018 $319,231 $200,000 $302,006 $1,689,835 — — $16,642 $2,527,714

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.